Treatment of Alzheimer disease and prognosis of dementia: time to translate research to results.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2010-11-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jama.2010.1625PMID 21045105
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer's disease: clinical trials and drug development

  2010cited by this paper
• Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines.

  2010cited by this paper
• Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.

  2010cited by this paper
• Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association

  2009cited by this paper
• Promising strategies for the prevention of dementia.

  2009cited by this paper
• Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience

  2008cited by this paper
• Patient and caregiver characteristics and nursing home placement in patients with dementia.

  2002cited by this paper

• GC/MS-Based Urine Metabolomics Study on the Ameliorative Effect of Xanthoceras sorbifolia Extract on Alzheimer's Disease in Mice

  2022cites this paper
• Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease

  2020cites this paper
• Echinacoside Suppresses Amyloidogenesis and Modulates F-actin Remodeling by Targeting the ER Stress Sensor PERK in a Mouse Model of Alzheimer’s Disease

  2020cites this paper
• Towards a more Comprehensive Approach to Non-Pharmacological Therapies for Alzheimer’s Disease and other Dementias

  2019cites this paper
• Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer's disease.

  2016cites this paper
• A new era of disease modeling and drug discovery using induced pluripotent stem cells

  2016cites this paper
• Docosahexaenoic acid supports feto‐placental growth and protects cardiovascular and cognitive function: A mini review

  2016cites this paper
• Impact of fatty acids on brain circulation, structure and function.

  2015cites this paper
• Conference on ‘ PUFA mediators : implications for human health ’ Symposium 1 : PUFA : health effects and health claims Ageing and apoE change DHA homeostasis : relevance to age-related cognitive decline

  2014cites this paper
• PNS1300362 80..86

  2014cites this paper
• Resveratrol as a Therapeutic Agent for Alzheimer's Disease

  2014cites this paper
• Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria.

  2013cites this paper
• Chapter 51 – What Is the Clinical Course of Advanced Dementia?

  2013cites this paper
• Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline

  2013cites this paper
• Aging, dementia, and disorders of cognition

  2013cites this paper
• Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence?

  2013influential citation
• A stepwise process for developing and implementing quality indicators to improve psychosocial dementia care in European countries

  2012cites this paper
• The New Calcium and Vitamin D DRIs: A Clinician's Guide

  2011cites this paper
• Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.

  2011cites this paper
• Themes of aging: preserving function, improving care.

  2010cites this paper